Financial Performance - The company's operating revenue for Q3 2021 reached ¥6,788,005,098.12, representing a year-on-year increase of 104.01%[7] - Net profit attributable to shareholders for the same period was ¥195,207,331.27, up 47.21% compared to the previous year[7] - The basic earnings per share for Q3 2021 was ¥0.15, reflecting a 50.00% increase year-on-year[9] - Total operating revenue for the first three quarters of 2021 reached ¥16,602,132,051.43, a significant increase from ¥9,814,690,527.23 in the same period of 2020, representing a growth of approximately 69.5%[32] - Net profit for the third quarter of 2021 was ¥730,754,108.13, compared to ¥432,192,547.17 in the third quarter of 2020, reflecting an increase of about 68.9%[35] - Total comprehensive income for the period attributable to the parent company was CNY 666,435,120.73, an increase from CNY 396,942,075.80 in the previous period, representing a growth of approximately 67.7%[37] - Basic earnings per share increased to CNY 0.52 from CNY 0.31, reflecting a growth of 67.7%[37] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥9,220,615,131.21, a 22.90% increase from the end of the previous year[9] - As of September 30, 2021, the total assets of the company reached CNY 9,220,615,131.21, an increase from CNY 7,502,734,517.63 at the end of 2020, representing a growth of approximately 22.8%[24] - The company's current assets totaled CNY 6,193,190,192.84, up from CNY 4,994,099,834.79 in the previous year, indicating a year-over-year increase of about 24.1%[27] - Total liabilities increased to ¥4,055,858,221.38 from ¥2,812,121,616.88, marking a rise of approximately 44.3%[30] - The company reported a significant increase in accounts payable, which rose to ¥1,910,874,530.43 from ¥1,568,993,025.10, indicating a growth of about 21.8%[30] Cash Flow - Cash inflow from operating activities totaled CNY 15,874,690,237.31, compared to CNY 10,197,529,168.74 in the previous period, marking an increase of approximately 55.8%[41] - Cash outflow from operating activities was CNY 15,924,113,065.25, up from CNY 9,404,816,900.55, indicating a rise of about 69.5%[41] - Net cash flow from operating activities was negative at CNY -49,422,827.94, a significant decline from CNY 792,712,268.19 in the previous period[41] - Cash inflow from investing activities was CNY 26,063,149.66, compared to CNY 4,501,667.48 in the previous period, showing an increase of approximately 479.5%[41] - Cash outflow from investing activities totaled CNY 519,095,296.24, up from CNY 69,680,581.03, representing a rise of about 645.5%[41] - Net cash flow from investing activities was negative at CNY -493,032,146.58, worsening from CNY -65,178,913.55 in the previous period[41] - Cash inflow from financing activities reached CNY 1,244,014,862.41, compared to CNY 204,900,000.00 in the previous period, an increase of approximately 505.0%[43] - Net cash flow from financing activities was CNY 531,844,532.99, a turnaround from CNY -115,559,891.98 in the previous period[43] Inventory and Expenses - The company reported a significant increase in inventory by 265.18%, attributed to the new medical supply chain logistics business[14] - The company's R&D expenses increased by 55.89%, indicating a commitment to transforming into a technology-driven logistics enterprise[16] - Research and development expenses for the third quarter of 2021 were ¥18,361,785.83, up from ¥11,778,311.27 in the same quarter of 2020, reflecting a growth of about 55.9%[32] - Operating costs for the first three quarters of 2021 were ¥15,715,711,092.71, compared to ¥9,304,382,239.04 in 2020, which is an increase of approximately 68.5%[32] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 30,289[16] - The total equity attributable to shareholders of the parent company rose to ¥4,936,767,451.26 from ¥4,585,633,853.06, an increase of approximately 7.7%[32] Future Outlook - The company has plans for market expansion and new product development to sustain growth momentum in the upcoming quarters[30] - The company has not disclosed any new product or technology developments during the reporting period[23] - There are no significant mergers or acquisitions reported in the current financial period[23] - The company has not provided specific future guidance or outlook in the current report[23]
华贸物流(603128) - 2021 Q3 - 季度财报